{
  "completed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" and the context provided seems to be about estimating infections and the impact of non-lockdown measures. Wait, the titles and passages are a bit confusing. Let me look again.\n\nThe context has four entries. The first three are titled \"Estimating the number of infections and the impact of non-\" with the passage \"Lockdown\" each time. The fourth title is the same but the passage is \"banned Implemented with lockdown.57 24/3/2020\". Hmm, maybe there's a typo or formatting issue here. The user probably wants me to use the context to answer the question about a lockdown.\n\nSince the context mentions \"non-lockdown\" and \"implemented with lockdown,\" maybe it's discussing measures taken during a pandemic. A lockdown typically refers to strict restrictions on movement and activities to control the spread of a disease. The context might be suggesting that non-lockdown measures were compared to lockdowns in terms of their effectiveness. But the user is asking for a definition of a lockdown. Even though the context is a bit unclear, I can rely on general knowledge here. A lockdown is a public health measure where people are required to stay at home, businesses close, and movement is restricted to prevent the spread of an infectious disease. The context might be part of a study analyzing the impact of such measures. Since the answer needs to be based on the context, but the context is minimal, I should focus on the key terms mentioned. The passage mentions \"implemented with lockdown,\" which implies that a lockdown is a specific measure put in place, possibly alongside other non-lockdown measures. So, combining that with the general understanding, the answer should define a lockdown as a strict restriction on movement and activities to control disease spread, as part of public health strategies.\n</think>\n\nA **lockdown** is a public health measure implemented to restrict movement and activities of people within a specific area or population to prevent the spread of an infectious disease, such as during a pandemic. It typically involves strict limitations on non-essential travel, closure of businesses, schools, and public spaces, and mandates for individuals to remain at home except for essential needs. The context provided suggests that lockdowns were compared to \"non-lockdown\" measures (e.g., less restrictive interventions) to assess their impact on reducing infections, as referenced in the passage \"banned Implemented with lockdown.57 24/3",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which is the Chikungunya virus. I need to go through the provided context and extract all the mentioned complications.\n\nFirst, looking at the first passage, it mentions that during the La Reunion Island outbreaks, mothers could transmit CHIKV to their babies during the perinatal period, leading to high morbidity. Neonates showed symptoms by day 4. Then there's a part about six neonates developing meningoencephalitis. Also, when mothers were infected long before delivery, there were three fetal deaths. So complications here include meningoencephalitis in neonates and fetal deaths.\n\nThe second passage lists several complications from most to least common. The main ones are respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other CNS problems, and kidney failure. It also notes that severe CHIKF (Chikungunya fever) is more common in those over 65 and those with underlying conditions. So those are the complications.\n\nI need to compile all these. The answer should list all the complications mentioned, including the neonatal issues like meningoencephalitis and fetal deaths, plus the other ones like respiratory failure, etc. Also, mention the high mortality rate in severe cases (over 33% die). Make sure to present them clearly, perhaps grouping the neonatal complications separately if needed. Check for any other details I might have missed, like the transplacental transmission theory. But the question is specifically about complications, so focus on the listed ones. Let me structure the answer with the main complications from the study and the neonatal ones.\n</think>\n\nThe complications associated with CHIKV (Chikungunya virus) include:  \n1. **Neonatal complications**:  \n   - Transmission from mother to child during the perinatal period, leading to high morbidity.  \n   - Neonates becoming symptomatic by Day 4 of life, exhibiting common CHIKF (Chikungunya fever) symptoms.  \n   - Development of **meningoencephalitis** in infected neonates (6 confirmed cases).  \n   - **Fetal deaths** (3 reported during the La Reunion Island epidemic when maternal infection occurred long before delivery).  \n\n2. **Severe adult complications** (from most to least common",
      "retrieved_chunks": [
        "Passage: and complications. Title: Chikungunya: A Potentially Emerging Epidemic? Passage: During the 2005-2006 La Reunion Island outbreaks, Ramful et al. discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms.",
        "Title: Chikungunya: A Potentially Emerging Epidemic? Passage: More than 50% of patients who suffer from severe CHIKF are over 65 y old, and more than 33% of them die. Most adults who suffer from severe CHIKF have underlying medical conditions . The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure .",
        "The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure . Title: Chikungunya: A Potentially Emerging Epidemic? Passage: and complications. Title: Chikungunya: A Potentially Emerging Epidemic?",
        "discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis. Of those mothers who, during the La Reunion Island epidemic, were infected long before delivery, only three fetal deaths were reported . Ramful et al.",
        "Of those mothers who, during the La Reunion Island epidemic, were infected long before delivery, only three fetal deaths were reported . Ramful et al. theorized that motherto-child transmission most likely happens transplacentally shortly before delivery . Title: Chikungunya: A Potentially Emerging Epidemic? Passage: A similar study by Gerardin et al."
      ],
      "computed_relevance": 0.4,
      "computed_utilization": 0.36,
      "computed_completeness": 0.9,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's try to figure out what Clade A contains based on the provided context. The user is asking about \"Clade A,\" but looking through the passages, I notice mentions of clades like 1A, 1B, 1C, and their subclades such as 1A.1, 1B.1, etc. There's no mention of a \"Clade A\" specifically. Instead, the text refers to lineages like 1A, 1B, and 1C, each with their own subdivisions.\n\nFor example, the 1A lineage is mentioned as containing 1,889 viruses from 34 countries collected from 2010 to the present. It's divided into three second-order divisions. The 1B lineage includes human seasonal lineage with exceptions in 1B.1 and 1B.2. The 1C lineage is discussed in relation to swine viruses in China and South Korea, with \"Other-Avian\" clades. \n\nThe user might be confusing \"Clade A\" with the 1A, 1B, 1C designations. Since there's no Clade A mentioned, perhaps the answer is that Clade A isn't defined in the context provided. Alternatively, if there's a misunderstanding in the numbering, maybe the answer refers to the 1A lineage. However, the question specifically says \"Clade A,\" which isn't present. Therefore, the correct answer would be that there is no Clade A mentioned; instead, there are lineages like 1A, 1B, 1C.\n</think>\n\nThe provided context does not mention a \"Clade A.\" Instead, it discusses lineages such as **1A**, **1B**, and **1C**, each with subdivisions (e.g., 1A.1, 1B.1, 1B.2, 1C.2). For example:  \n- **1A lineage**: Contains 1,889 viruses from 34 countries (2010\u2013present), subdivided into three second-order clades.  \n- **1B lineage**: Includes human seasonal lineage with exceptions in subclades 1B.1 and 1B.2.  \n- **1C lineage**: Comprises swine viruses from China and South Korea, with \"Other-Avian\"",
      "retrieved_chunks": [
        "For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades . The 1B.1 second-order clade had too few representative sequences to calculate genetic distance, and 1B.2 represented multiple monophyletic clades that individually did not meet our criteria for further division. Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting. The exception to the between-clade threshold was associated with clades\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: were placed into seven clades.",
        "Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting. The exception to the between-clade threshold was associated with clades\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: were placed into seven clades. The numerically dominant clades reflected intensive surveillance in the United States , investigator sequencing efforts in Canada , and the rapid dissemination of the 2009 H1N1 pandemic virus across global swine populations . Similarly, coordinated surveillance in Europe and Asia captured two primary clades of 1C Eurasian avian lineage currently circulating in the two continents.",
        "Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception. Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage. The 1C lineage consisted of 315 viruses from 14 countries collected from 2010 to the present in China and South Korea. Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 . For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade.",
        "Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 . For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade. The one within-clade exception in this lineage was 1C.2 , which had multiple monophyletic\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: The 1B human seasonal lineage within-and between-clade APDs are presented in Table 3 . For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades .",
        "Title: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1A swine lineage. The 1A lineage contained 1,889 viruses from 34 countries collected from 2010 to the present . According to our nomenclature rules, we refined the classification of 1A viruses into three second-order divisions, each of which corresponds to earlier, regional classifica- Table 2 . Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception. Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage."
      ],
      "computed_relevance": 0.7083333333333334,
      "computed_utilization": 0.7083333333333334,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. \n\nFirst, I need to look through the provided context for relevant information. The context includes several passages from a paper titled \"Genomic characterization of the 2019 novel human-pathogenic coronavirus...\" which seems to discuss the genetic structure of the virus.\n\nLooking at the first passage mentioned, it says: \"the S1 subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV\". So that's a direct comparison. The S1 subunit has about 70% identity with those viruses. \n\nAnother part of the context mentions that the core domain of the RBD (receptor-binding domain) is highly conserved. However, most amino acid differences in the RBD are in the external subdomain, which interacts directly with the host receptor. This suggests that while the core is similar, the parts that interact with the host might differ more.\n\nAdditionally, another passage states that the external subdomain of the Spike's RBD in 2019-nCoV shares only 40% amino acid identity with other SARS-related coronaviruses. This seems to highlight that the S1 subunit's external part is less conserved compared to the core. \n\nPutting this together, the S1 subunit of 2019-nCoV has about 70% identity with SARS-like CoVs and human SARS-CoV overall. However, the core RBD is conserved, but the external subdomain, which is crucial for receptor interaction, is less conserved (40% identity). This difference in the external subdomain might explain variations in host receptor usage and transmission between these viruses.\n\nI should make sure there's no conflicting information. The key points are the 70% identity for the S1 subunit overall and the 40% for the external RBD subdomain. The answer should reflect both the overall identity and the specific differences in the RBD's external part.\n</think>\n\nThe S1 subunit of 2019-nCoV shares **around 70% identity** with the S1 subunits of bat SARS-like coronavir",
      "retrieved_chunks": [
        "Thus the broad spectrum antiviral peptides against S2 would be an important preventive and treatment modality for testing in animal models before clinical trials . Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ). Most of the amino acid differences of RBD are located in the external subdomain, which is responsible for the direct interaction with the host receptor. Further investigation of this soluble variable external subdomain region will reveal its receptor usage, interspecies transmission and pathogenesis. Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV.",
        "Further investigation of this soluble variable external subdomain region will reveal its receptor usage, interspecies transmission and pathogenesis. Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV. But some\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: bat, civet and human SARS coronaviruses. However, the external subdomain of Spike\u2019s receptor binding domain of 2019-nCoV shares only 40% amino acid identity with other SARS-related coronaviruses. Remarkably, its orf3b encodes a completely novel short protein.",
        "However, the external subdomain of Spike\u2019s receptor binding domain of 2019-nCoV shares only 40% amino acid identity with other SARS-related coronaviruses. Remarkably, its orf3b encodes a completely novel short protein. Furthermore, its new orf8 likely encodes a secreted protein with an alpha-helix, following with a beta-sheet containing six strands. Learning from the roles of civet in SARS and camel in MERS, hunting for the animal source of 2019-nCoV and its more ancestral virus would be important for understanding the origin and evolution of this novel lineage B betacoronavirus. These findings provide the basis for\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: As shown in Figure 7 , the SARS-CoV 5 \u2032 -UTR contains SL1, SL2, SL3, SL4, S5, SL5A, SL5B, SL5C, SL6, SL7, and SL8.",
        "Learning from the roles of civet in SARS and camel in MERS, hunting for the animal source of 2019-nCoV and its more ancestral virus would be important for understanding the origin and evolution of this novel lineage B betacoronavirus. These findings provide the basis for\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: As shown in Figure 7 , the SARS-CoV 5 \u2032 -UTR contains SL1, SL2, SL3, SL4, S5, SL5A, SL5B, SL5C, SL6, SL7, and SL8. The SL3 contains trans-cis motif . The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV.",
        "Title: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: Spike glycoprotein comprised of S1 and S2 subunits. The S1 subunit contains a signal peptide, followed by an N-terminal domain and receptor-binding domain , while the S2 subunit contains conserved fusion peptide , heptad repeat 1 and 2, transmembrane domain , and cytoplasmic domain . We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV . Thus the broad spectrum antiviral peptides against S2 would be an important preventive and treatment modality for testing in animal models before clinical trials . Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved )."
      ],
      "computed_relevance": 0.08,
      "computed_utilization": 0.08,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" and they provided some context from a research paper titled \"Secretome of Intestinal Bacilli: A Natural Guard against Pathologies.\" \n\nFirst, I need to parse through the given context to find relevant information about B. subtilis. The passage mentions that B. subtilis is a probiotic used in treating intestinal diseases like colitis. It helps restore gut microflora by increasing beneficial species (Bifidobacterium, Lactobacillus, Butyricicoccus) and decreasing harmful ones (Acinetobacter, Ruminococcus, Clostridium, Veillonella). Also, it retains gut barrier integrity, reduces endotoxins, and decreases inflammation. \n\nAnother part of the context says that Bacillus species, including B. subtilis, were once thought to be transient in the gut but are now known to be well-adapted and colonizing. Additionally, B. subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and anti-inflammatory properties.\n\nSo, putting this together, Bacillus subtilis is a probiotic bacterium that's part of the Bacillus genus. It's used for its health benefits in the gut, producing substances that fight pathogens and reduce inflammation. It's found in the human gut and helps maintain a healthy microbiome by balancing the bacterial populations. The answer should mention its role as a probiotic, its effects on gut health, the specific compounds it produces, and its presence in the gut microbiome.\n</think>\n\nBacillus subtilis is a probiotic bacterium belonging to the Bacillus genus, known for its beneficial effects on gut health. It is part of the intestinal microbiome and has been shown to restore balance in gut microflora by increasing beneficial species (e.g., *Bifidobacterium*, *Lactobacillus*, *Butyricicoccus*) and reducing harmful, gut-damaging species (e.g., *Acinetobacter*, *Clostridium*). *B. subtilis* produces antimicrobial and anti-inflammatory compounds like surfactins, fengycins, and iturins, which protect against pathogens, reduce gut inflammation, and maintain intestinal barrier integrity. Once considered transient in the gut, recent studies confirm its ability",
      "retrieved_chunks": [
        "were increased, while gut damage-promoting species of Acinetobacter sp., Ruminococcus sp., Clostridium spp., and Veillonella sp. were decreased . B. subtilis also retained gut barrier integrity, decreased the endotoxin concentration and reduced gut inflammation Bene et al., 2017) . Sporulation of B.",
        "Title: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: The efficacy of Lactobacillus and Bacillus in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer was demonstrated . In particular, treatment of colorectal colitis in mice with probiotic B. subtilis restored balance in gut microflora: beneficial species of Bifidobacterium, Lactobacillus, and Butyricicoccus spp. were increased, while gut damage-promoting species of Acinetobacter sp., Ruminococcus sp., Clostridium spp., and Veillonella sp. were decreased .",
        "as soil microorganisms were considered transient. Recent studies show that they are present in the GIT in the amounts significantly higher than what can be explained by their ingestion with food only. Bacillus spp. have been isolated from the healthy human GIT, where they are well-adapted and are more colonizing than transient . In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B.",
        "In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome. Being isolated from feces, Bacillus spp. as soil microorganisms were considered transient. Recent studies show that they are present in the GIT in the amounts significantly higher than what can be explained by their ingestion with food only.",
        "have been isolated from the healthy human GIT, where they are well-adapted and are more colonizing than transient . In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B. subtilis produces surfactins, fengycins and iturins in a ratio of 6:37:57 . The less abundant surfactins unlike other types of Bacillus lipopeptides exhibit a broad range of antimicrobial activities and possess antiviral action . They protect bacilli against extracellular antibiotic-containing vesicles of other species and inhibit phospholipase A2 resulting in subsequent downregulation of pro-inflammatory cytokines and upregulation of anti-inflammatory cytokines ."
      ],
      "computed_relevance": 0.4,
      "computed_utilization": 0.36,
      "computed_completeness": 0.9,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. First, I need to look through the provided contexts to find relevant information.\n\nLooking at the first context, it talks about the 1889 pandemic having three major waves, with the 1892 wave being the most intense. It also mentions the 1918 pandemic's herald waves possibly starting in 1915. However, this seems to be about multi-wave pandemics, not single-wave. So maybe not directly relevant, but perhaps there's something else here.\n\nThe second context is about the 2009 pH1N1 pandemic in Hong Kong. It mentions research on convalescent plasma and studies on the origins and pathogenesis of the virus. However, the 2009 pandemic is discussed in terms of epidemiology and control, but I don't see mention of it being a single wave. The passage also references other studies but doesn't specify wave patterns.\n\nThird context is about influenza virus circulation in Taiwan from 2008-2014, focusing on the 2009 pH1N1 pandemic. It discusses using the Richards model for multi-wave epidemics, distinguishing between different turning points. This seems to be about modeling multi-wave scenarios, so again, not directly about single-wave.\n\nThe fourth context is an economic analysis of mitigation strategies for five pandemic severity categories, using data from the 2009 pandemic. It mentions considering varying interventions and durations but doesn't specify if the 2009 pandemic was single or multi-wave. The 2009 pandemic might have had multiple waves, but the context here is about modeling different severities, not the wave structure.\n\nWait, the user is asking about severe, single-wave pandemics. The contexts provided don't explicitly mention single-wave pandemics. The 1889 pandemic had three waves, 1918 had multiple waves. The 2009 pH1N1 might have had multiple waves too. The studies mentioned in the contexts are about modeling interventions, origins, and economic impacts, but not specifically about single-wave events.\n\nIs there any mention of a single-wave pandemic in the contexts? The first context's 1892 wave was the most intense, but it's part of a three-wave pandemic. The other contexts don't mention single-wave. Maybe",
      "retrieved_chunks": [
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies. 56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review. To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis.",
        ". The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic. Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave.",
        "56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review. To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al. . The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic."
      ],
      "computed_relevance": 0.0,
      "computed_utilization": 0.8461538461538461,
      "computed_completeness": 0.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's try to figure out how many reported viral pneumonia cases there are based on the provided context. The user is asking for the number of reported viral pneumonia cases, so I need to look through the passages to find any mention of numbers related to viral pneumonia.\n\nFirst, looking at the titles and passages. The first passage talks about bacterial co-infection in the 2009 H1N1 pandemic, mentioning 77 fatal cases. But that's about bacterial co-infection, not the total viral pneumonia cases. The next passage mentions influenza attack rates varying between 10-20% seasonally, higher during pandemics. Then there's a specific example from La Gloria with 29% and 61% attack rates in different age groups. But again, these are attack rates, not the actual number of cases.\n\nThe third title is about pneumonia in adults hospitalized with seasonal influenza in the US from 2005\u20132008. It mentions patients with pneumonia more likely to receive antivirals, but no specific numbers on cases.\n\nThe key part might be the fifth title about the 2019-nCoV (COVID-19) pneumonia. The passage states: \"At 24:00 on 26 January 2020, the National Health Commission... recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection...\" Then it mentions confirmed cases from Hong Kong, Macao, and Taiwan, but the sentence cuts off. However, the main number given here is 2744 confirmed cases of pneumonia with 2019-nCoV. \n\nThe question is about \"reported viral pneumonia,\" and since the context includes this specific number from the 2019-nCoV passage, that's likely the answer. The other passages discuss influenza, but the question might be referring to the most recent or specific data provided, which is the 2019-nCoV (COVID-19) cases. The user might be asking about the total reported cases in the context provided, which is 2744. However, the last sentence in the fifth passage mentions \"A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\" but it doesn't provide a number. The main number given is 2744, so that's probably",
      "retrieved_chunks": [
        "A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients . The most common coinfecting bacterial pathogens were pneumococcus, Staphylococcus aureus, and Streptococcus pyogenes, with a median duration of illness of 6 days . Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics.",
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age . However, these rates may be different in geographic areas of low population density. Title: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01].",
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths. A total of 51 cases have been cured and discharged. At present, 5794 suspected cases were recorded, 32,799 with close contacts to the confirmed patients have been tracked, 583 people were released from medical observation that day, and 30,453 people were still undergoing medical observation. A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients ."
      ],
      "computed_relevance": 0.13333333333333333,
      "computed_utilization": 0.4666666666666667,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the relevant information.\n\nLooking through the passages, I remember one mentioned high throughput or \"deep\" sequencing methods. Let me check again. Here's a passage: \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems to directly answer the question. \n\nAnother part of the same passage says that MERS-CoV was the first subject of widespread use of deep sequencing for an emerging viral outbreak. So the answer should focus on high throughput or deep sequencing methods. I need to make sure there's no other method mentioned as primary. The other passages talk about whole genome sequencing, but the key here is that the main method is high throughput/deep sequencing. Let me confirm there's no conflicting info. The answer is clear in the context provided.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been performed using **high throughput or \"deep\" sequencing methods** for complete genome deduction. This approach enabled extensive study of the virus's genetic variations and was notably applied to track its global spread and evolution.",
      "retrieved_chunks": [
        "The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable. Among all humans reported to be infected, nearly 40 % have died. Continued laboratory testing, sequencing, analysis, timely data sharing and clear communication are essential for such vigilance to be effective. Global alignment of case definitions would further aid accurate calculation of a case fatality ratio by including subclinical case numbers. Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants.",
        "Global alignment of case definitions would further aid accurate calculation of a case fatality ratio by including subclinical case numbers. Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants. While human and camel whole genome sequences have retained >99 % identity with each other, members of genetically distinct lineages can and do swap genetic material when suitable conditions and coinfections co-occur . Shared identity implies that the major source for human acquisition is the DC, rather than another animal, although more testing of other animal species is needed to confirm that conclusion. Over a month, a DC",
        "Earlier and subsequent versions of this chart are maintained on a personal blog length coverage in a single experiment with highly repetitious measurement of each nucleotide position . Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable. Among all humans reported to be infected, nearly 40 % have died.",
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach. The technique can produce genomic . Earlier and subsequent versions of this chart are maintained on a personal blog length coverage in a single experiment with highly repetitious measurement of each nucleotide position . Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins ."
      ],
      "computed_relevance": 0.05,
      "computed_utilization": 0.05,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the spread of GFP-expressing virus-infected cells was tracked. I need to look through the provided context to find the relevant information.\n\nFirst, I remember the context mentions using IVIS for whole-organ imaging in mice. IVIS stands for In Vivo Imaging System, which is used for bioluminescence or fluorescence imaging. So that's one method. Then there's flow cytometry mentioned for analyzing infection progression in antigen-presenting cells. Flow cytometry allows for the analysis of cells as they pass through a laser, detecting fluorescent markers like GFP. \n\nThe context also talks about multi-photon intravital microscopy. This technique is used for in vivo imaging, allowing visualization of structures in living organisms with high resolution. The passage mentions that using a 10^6 PFU intranasal inoculation, they observed GFP expression in dendritic cells, macrophages, and neutrophils at 48 hours post-infection. \n\nAdditionally, there's mention of imaging plates with an inverted fluorescence microscope and a CellInsight CX5 High Content Screening Platform. These are probably in vitro methods, but the question is about tracking spread, which might involve both in vivo and in vitro techniques. However, the main tracking in the context seems to focus on the in vivo methods like IVIS and flow cytometry. \n\nThe answer should include IVIS for whole-organ imaging, flow cytometry for analyzing specific cell types, and possibly multi-photon intravital microscopy for detailed in vivo tracking. Also, the use of GFP as a reporter gene allows for visualization through these techniques. The context also notes that the GFP expression was monitored over time, indicating longitudinal studies to track spread progression.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked using **in vivo imaging techniques** such as **IVIS (In Vivo Imaging System)** for whole-organ imaging of murine lungs and **flow cytometry** to analyze infection progression in antigen-presenting cells (e.g., dendritic cells, macrophages, and neutrophils). Additionally, **multi-photon intravital microscopy** was employed to visualize GFP expression in living tissues with high resolution, enabling real-time tracking of viral spread from the respiratory tract to deeper lung regions. For in vitro monitoring, **fluorescence microscopy** (e.g., inverted fluorescence microscopes and high-content screening platforms like CellInsight CX",
      "retrieved_chunks": [
        "Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs . The authors found that using a 10 6 PFU intranasal inoculation, 10% of dendritic cells were observed to express GFP and 2%-3% of macrophages and neutrophils were also GFP+ at 48 h post-infection .",
        "One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black . Title: Visualizing Viral Infection In Vivo by Multi-Photon Intravital Microscopy\nPassage: express cytoplasmic fluorescent proteins driven e.g., by the chicken \u03b2-actin promoter with cytomegalovirus enhancer or human ubiquitin C promoter . Many different mouse lines are available that contain reporter genes for cytoplasmic fluorescent proteins such as EGFP and mCherry . Due to strong and continuous expression rate of the fluorescent proteins long-term tracking of dividing cells without extensive bleaching is possible. In addition, with a superior signal-to-noise ratio visualization of small cellular structures with low cytoplasm content is feasible.",
        "Due to strong and continuous expression rate of the fluorescent proteins long-term tracking of dividing cells without extensive bleaching is possible. In addition, with a superior signal-to-noise ratio visualization of small cellular structures with low cytoplasm content is feasible. Although the approach to adoptively transfer fluorescent cells of interest into donor mice for functional imaging studies is fast and flexible,\n\nTitle: Replication-Competent Influenza A Viruses Expressing Reporter Genes\nPassage: lungs. Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs .",
        "Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed . From that time forward, a square subset of the center of each well was imaged periodically, using a CellInsight CX5 High Content Screening Platform with a 4X air objective . Microscope settings were held standard across all trials, with exposure time fixed at 0.0006 s for each image. One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black . Title: Visualizing Viral Infection In Vivo by Multi-Photon Intravital Microscopy\nPassage: express cytoplasmic fluorescent proteins driven e.g., by the chicken \u03b2-actin promoter with cytomegalovirus enhancer or human ubiquitin C promoter .",
        "Title: Illuminating the Sites of Enterovirus Replication in Living Cells by Using a Split-GFP-Tagged Viral Protein\nPassage: transduction, the MLV particles were 5 to 10 times concentrated using a 100-kDa concentrator . For the generation of single-cell clones stably expressing GFP, BGM and HeLa cells were transduced and grown in the presence of puromycin to generate pools of GFP-expressing cells, which were subsequently used to prepare single-cell clones by limiting dilution. Expression of GFP was monitored during passaging by immunofluorescence microscopy using the GFP antibody. Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed . From that time forward, a square subset of the center of each well was imaged periodically, using a CellInsight CX5 High Content Screening Platform with a 4X air objective ."
      ],
      "computed_relevance": 0.17391304347826086,
      "computed_utilization": 0.17391304347826086,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages with similar titles and mentions of CT disinfection procedures. \n\nFirst, I need to parse the context. The titles all mention \"The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\" and the passages talk about noncontaminated CT disinfection procedures after suspected cases, fever-CT disinfection, and preparing to disinfect imaging equipment immediately after examination.\n\nThe key points here are that after examining a suspected COVID-19 case, the CT equipment needs to be disinfected. The passages mention \"immediately after the examination\" and \"sterilization procedures.\" The term \"noncontaminated CT disinfection procedures\" might be a bit confusing, but since they're talking about after the examination, it's likely referring to the standard disinfection process even if the CT was used for a suspected case. \n\nThe answer should probably include steps like immediate disinfection after the exam, using appropriate sterilization methods, and ensuring that the equipment is properly cleaned. Since the context doesn't go into specific chemicals or steps beyond the general procedure, the answer should be concise, focusing on the timing and the action taken. The user might be looking for a confirmation that immediate disinfection is the key step here. I need to make sure the answer reflects that the procedure is to disinfect the CT scanner right after the examination using the specified sterilization protocols mentioned in the context.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves **immediately disinfecting the imaging equipment after the examination** using established sterilization protocols. This includes following noncontaminated CT disinfection procedures to ensure all surfaces and equipment are thoroughly cleaned to prevent cross-contamination. The process emphasizes prompt action post-examination to mitigate viral transmission risks.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures. Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}